Your browser doesn't support javascript.
loading
NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner.
Waqas, Fakhar H; Shehata, Mahmoud; Elgaher, Walid A M; Lacour, Antoine; Kurmasheva, Naziia; Begnini, Fabio; Kiib, Anders E; Dahlmann, Julia; Chen, Chutao; Pavlou, Andreas; Poulsen, Thomas B; Merkert, Sylvia; Martin, Ulrich; Olmer, Ruth; Olagnier, David; Hirsch, Anna K H; Pleschka, Stephan; Pessler, Frank.
Afiliação
  • Waqas FH; Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany.
  • Shehata M; Research Group Biomarkers for Infectious Diseases, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Elgaher WAM; Institute of Medical Virology, Justus-Liebig-University Giessen, Giessen, Germany.
  • Lacour A; National Research Centre, Giza, Egypt.
  • Kurmasheva N; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany.
  • Begnini F; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany.
  • Kiib AE; Institute for Experimental Infection Research, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany.
  • Dahlmann J; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  • Chen C; Department of Chemistry, Aarhus University, Aarhus, Denmark.
  • Pavlou A; Department of Chemistry, Aarhus University, Aarhus, Denmark.
  • Poulsen TB; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surgery (HTTG), REBIRTH-Research Center for Translational and Regenerative Medicine, Hannover Medical School, Hannover, Germany.
  • Merkert S; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
  • Martin U; Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany.
  • Olmer R; Research Group Biomarkers for Infectious Diseases, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Olagnier D; Institute for Experimental Infection Research, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany.
  • Hirsch AKH; Department of Chemistry, Aarhus University, Aarhus, Denmark.
  • Pleschka S; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surgery (HTTG), REBIRTH-Research Center for Translational and Regenerative Medicine, Hannover Medical School, Hannover, Germany.
  • Pessler F; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
PLoS Pathog ; 19(7): e1011506, 2023 07.
Article em En | MEDLINE | ID: mdl-37459366

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Vírus da Influenza A Subtipo H1N1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Vírus da Influenza A Subtipo H1N1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2023 Tipo de documento: Article